HHGA
Halbert Hargrove Global Advisors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Sell |
1,848
-28
| -1% | -$21.8K | 0.08% | 34 |
|
|
2025
Q1 | $1.55M | Buy |
1,876
+28
| +2% | +$23.1K | 0.09% | 31 |
|
|
2024
Q4 | $1.43M | Sell |
1,848
-290
| -14% | -$224K | 0.08% | 33 |
|
|
2024
Q3 | $1.89M | Hold |
2,138
| – | – | 0.1% | 29 |
|
|
2024
Q2 | $1.94M | Sell |
2,138
-55
| -3% | -$49.8K | 0.11% | 29 |
|
|
2024
Q1 | $1.71M | Buy |
2,193
+11
| +0.5% | +$8.56K | 0.11% | 34 |
|
|
2023
Q4 | $1.27M | Buy |
2,182
+8
| +0.4% | +$4.66K | 0.09% | 37 |
|
|
2023
Q3 | $1.17M | Sell |
2,174
-22
| -1% | -$11.8K | 0.09% | 37 |
|
|
2023
Q2 | $1.03M | Sell |
2,196
-1,238
| -36% | -$581K | 0.08% | 35 |
|
|
2023
Q1 | $1.18M | Sell |
3,434
-562
| -14% | -$193K | 0.08% | 41 |
|
|
2022
Q4 | $1.46M | Buy |
3,996
+90
| +2% | +$32.9K | 0.1% | 35 |
|
|
2022
Q3 | $1.26M | Buy |
3,906
+13
| +0.3% | +$4.2K | 0.1% | 38 |
|
|
2022
Q2 | $1.26M | Buy |
3,893
+2,266
| +139% | +$735K | 0.09% | 37 |
|
|
2022
Q1 | $466K | Buy |
1,627
+33
| +2% | +$9.45K | 0.03% | 75 |
|
|
2021
Q4 | $440K | Buy |
1,594
+5
| +0.3% | +$1.38K | 0.03% | 81 |
|
|
2021
Q3 | $367K | Sell |
1,589
-16
| -1% | -$3.7K | 0.03% | 83 |
|
|
2021
Q2 | $368K | Hold |
1,605
| – | – | 0.02% | 86 |
|
|
2021
Q1 | $300K | Sell |
1,605
-86
| -5% | -$16.1K | 0.02% | 87 |
|
|
2020
Q4 | $285K | Sell |
1,691
-17
| -1% | -$2.87K | 0.02% | 81 |
|
|
2020
Q3 | $253K | Sell |
1,708
-5
| -0.3% | -$741 | 0.02% | 77 |
|
|
2020
Q2 | $281K | Buy |
1,713
+92
| +6% | +$15.1K | 0.04% | 63 |
|
|
2020
Q1 | $225K | Sell |
1,621
-22
| -1% | -$3.05K | 0.04% | 68 |
|
|
2019
Q4 | $216K | Buy |
+1,643
| New | +$216K | 0.06% | 70 |
|
|
2015
Q3 | – | Sell |
-2,920
| Closed | -$244K | – | 140 |
|
|
2015
Q2 | $244K | Buy |
2,920
+42
| +1% | +$3.51K | 0.06% | 159 |
|
|
2015
Q1 | $209K | Buy |
+2,878
| New | +$209K | 0.07% | 174 |
|